News & Events

Press Releases

Salarius Pharmaceuticals to Present at the 29th Annual Oppenheimer Healthcare Conference

Houston, TX, March 18, 2019 –Salarius Pharmaceuticals, LLC, a clinical-stage oncology company targeting the epigenetic causes of cancers, announced today that its Chief Executive Officer David...

Salarius Pharmaceuticals and Flex Pharma Announce Merger Agreement

Jan 4, 2019 @ 9:00am ET Click here to listen to the webcast: https://edge.media-server.com/m6/p/bptkbubn (more…)

Salarius to Attend JP Morgan 2019

January 6-10, 2019 Salarius is attending the 36th Annual healthcare conference. JP Morgan is the premier investor conference and we are excited to be attending once...

Salarius Attends Vision Tech Angels Portfolio Summit

December 12, 2018 @ 10:00am Pacific Salarius presents the significant progress made in 2H2018. Announces Goals for 2019 which include completing Phase 1 dose escalation...

Events

29th Annual Oppenheimer Healthcare Conference

Mar 20 @ 11:30a.m. ET

Listen to Webcast

31st Annual ROTH Conference

Mar 17 - Mar 19

Salarius Pharmaceuticals and Flex Pharma Announce Merger Agreement

Jan 4 @ 9:00am ET

Listen to Webcast

In the News

TheFly Speaks with Salarius CEO David Arthur

Houston Business Journal

Houston Oncology Co. Aims to Grow After Merger Announcement

Pharmaceutical Executive

Biopharmaceutical Enterprises Pursue Unconventional Paths to Public Markets

Houston Chronical

Houston-based Salarius to merge with Flex Pharma

Houston Business Journal

Houston oncology co. to merge with Boston’s struggling Flex Pharma

Houston Business Journal

Pharma company to relocate to Houston following CPRIT grant